186 related articles for article (PubMed ID: 14602236)
1. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.
Chang CC; Murphy SP; Ferrone S
Hum Immunol; 2003 Nov; 64(11):1057-63. PubMed ID: 14602236
[TBL] [Abstract][Full Text] [Related]
2. HLA-G in melanoma: can the current controversies be solved?
Chang CC; Ferrone S
Semin Cancer Biol; 2003 Oct; 13(5):361-9. PubMed ID: 14708716
[TBL] [Abstract][Full Text] [Related]
3. Exosomes bearing HLA-G are released by melanoma cells.
Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
Bukur J; Malenica B; Huber C; Seliger B
Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia modulates HLA-G gene expression in tumor cells.
Mouillot G; Marcou C; Zidi I; Guillard C; Sangrouber D; Carosella ED; Moreau P
Hum Immunol; 2007 Apr; 68(4):277-85. PubMed ID: 17400064
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line.
Riteau B; Moreau P; Menier C; Khalil-Daher I; Khosrotehrani K; Bras-Goncalves R; Paul P; Dausset J; Rouas-Freiss N; Carosella ED
Transplant Proc; 2001 May; 33(3):2360-4. PubMed ID: 11377559
[No Abstract] [Full Text] [Related]
9. Modulation of HLA-G expression.
Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
[TBL] [Abstract][Full Text] [Related]
10. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
[TBL] [Abstract][Full Text] [Related]
11. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
12. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
13. HLA-G in skin cancer: a wolf in sheep's clothing?
Urosevic M; Dummer R
Hum Immunol; 2003 Nov; 64(11):1073-80. PubMed ID: 14602238
[TBL] [Abstract][Full Text] [Related]
14. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
15. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment.
Frumento G; Franchello S; Palmisano GL; Nicotra MR; Giacomini P; Loke YW; Geraghty DE; Maio M; Manzo C; Natali PG; Ferrara GB
Tissue Antigens; 2000 Jul; 56(1):30-7. PubMed ID: 10958353
[TBL] [Abstract][Full Text] [Related]
16. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
17. HLA-G gene repression is reversed by demethylation.
Moreau P; Mouillot G; Rousseau P; Marcou C; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1191-6. PubMed ID: 12552087
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells.
Fukushima Y; Oshika Y; Nakamura M; Tokunaga T; Hatanaka H; Abe Y; Yamazaki H; Kijima H; Ueyama Y; Tamaoki N
Int J Mol Med; 1998 Sep; 2(3):349-51. PubMed ID: 9855710
[TBL] [Abstract][Full Text] [Related]
19. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
Poláková K; Bandzuchová E; Kuba D; Russ G
Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
[TBL] [Abstract][Full Text] [Related]
20. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
